What Are The Harmful Things That Science Has Done

Science gave us antibiotics. It gave us vaccines, anesthesia, the ability to sequence a genome in hours instead of years. It put humans on the moon and put a supercomputer in your pocket.

But if you only tell that story, you're telling half of it.

The other half is messier. It's the radium dial painters whose jaws rotted away because their employers told them the paint was safe. It's the Tuskegee study, where hundreds of Black men were denied treatment for syphilis for forty years so researchers could watch the disease progress. It's the lobotomy craze that left thousands of people permanently disabled, performed by a man who won a Nobel Prize for it.

Science doesn't have intentions. In real terms, people do. And people — scientists, institutions, governments, corporations — have used the authority of science to justify some genuinely terrible things.

This isn't an anti-science piece. It's an honest one. Here's what happens when the pursuit of knowledge gets untethered from ethics, oversight, or basic human decency.

What We Mean When We Talk About Science Doing Harm

Science itself is a method. It doesn't "do" anything. So naturally, a way of testing ideas against reality. But the enterprise* of science — the institutions, the funding structures, the career incentives, the way findings get translated into policy and products — that's where harm lives.

Sometimes the harm is direct and intentional: weaponizing biology, conducting non-consensual experiments, designing chemicals known to be toxic because they're profitable.

Sometimes it's structural: research priorities that ignore diseases of the poor, publication bias that buries negative results, algorithms trained on biased data that then automate discrimination.

And sometimes it's the slow, grinding harm of hubris — the certainty that this time* we understand the system well enough to intervene, followed by the discovery that we didn't.

The difference between misuse and inherent risk

It's worth distinguishing. The physics didn't choose. The application* did. Nuclear physics gave us both cancer treatments and Hiroshima. But the scientists who built the bomb knew what it was for. Consider this: many regretted it later. Some didn't.

That distinction matters because it tells you where the guardrails need to go. Not on the knowledge itself — you can't un-discover fission — but on the institutions that decide how knowledge gets used.

Why This Conversation Matters Now

We're in a moment where scientific authority is both more powerful and more contested than ever.

mRNA vaccines were developed in record time and saved millions of lives. The same platform technology could, in theory, be adapted for applications that raise serious ethical questions. And aI systems trained on scientific literature are already being used to design novel proteins — and potentially novel toxins. Gene editing tools like CRISPR are cheap enough that a motivated graduate student could, in principle, attempt human germline editing in a garage lab.

The stakes are higher. The speed is faster. The barriers to entry are lower.

And public trust is fracturing. " But those institutions have earned skepticism. When people say "trust the science," they often mean "trust the institutions.The opioid epidemic fueled by pharma-funded research. Still, the replication crisis in psychology and biomedicine. The climate denial campaigns funded by fossil fuel interests using the language of scientific debate.

You can't rebuild trust by pretending the harm never happened. You rebuild it by naming it, understanding how it happened, and changing the structures that allowed it.

Historical Harms: The Cases That Shaped Modern Ethics

Tuskegee and the birth of informed consent

Between 1932 and 1972, the U.In practice, " They weren't. Public Health Service enrolled 600 Black men in Alabama — 399 with syphilis, 201 without — in a study of the disease's "natural history." The men were told they were being treated for "bad blood.S. Even after penicillin became the standard cure in 1947, researchers actively prevented participants from accessing it.

The study ended only when a whistleblower leaked it to the press.

Tuskegee didn't just violate ethics. Also, it created the modern framework for human subjects protection: the Belmont Report, institutional review boards (IRBs), the requirement for informed consent. Every clinical trial today operates in its shadow.

But the damage to trust in Black communities persists. Vaccine hesitancy, lower clinical trial enrollment, avoidance of medical care — researchers have documented direct lines from Tuskegee to present-day health disparities.

The radium girls and industrial denial

In the 1910s and 20s, young women painted watch dials with radium-based luminous paint. They were taught to point their brushes with their lips. Management knew radium was dangerous — scientists at the company used lead screens and tongs. In real terms, the women were told it was harmless. Some even painted their nails and teeth with it for fun.

Their jaws literally disintegrated. They died in agony. The companies fought compensation for years, hiring doctors to falsify records and claim the women had syphilis instead.

This wasn't rogue science. It was corporate science protecting profits. On the flip side, the pattern repeats: asbestos, leaded gasoline, PFAS, opioids. The playbook is always the same — fund favorable research, suppress unfavorable research, attack the credibility of independent scientists, delay regulation until the evidence is undeniable.

Want to learn more? We recommend writing the formula of your unknown salt and heat effects and calorimetry advance study assignment for further reading.

Lobotomy: when a Nobel Prize legitimizes harm

António Egas Moniz won the 1949 Nobel Prize in Physiology or Medicine for developing the prefrontal lobotomy. By the early 1950s, tens of thousands had been performed in the U.S. alone — often on women, often for "difficult" behavior rather than severe psychosis. Walter Freeman, the procedure's American popularizer, performed them in hotel rooms using an ice pick through the eye socket. He photographed the results like trophies.

The Soviet Union banned the procedure in 1950 as "contrary to the principles of humanity.Even so, " The U. S. kept doing it for another decade.

The lesson isn't that Moniz was evil. But it's that the scientific establishment — the Nobel Committee, the medical journals, the hospitals — validated a procedure with almost no rigorous evidence because it seemed* to work and filled a desperate need. Desperation lowers evidentiary standards. That's still true today.

Nuclear testing and downwinders

Between 1951 and 1992, the U.S. conducted over 900 nuclear tests at the Nevada Test Site. Radioactive fallout drifted over Utah, Arizona, and Nevada. Which means the government told residents it was safe. Sheep died by the thousands. Children developed leukemia at rates far above national averages. The Atomic Energy Commission classified the data.

It took decades of lawsuits and congressional hearings to get partial compensation through the Radiation Exposure Compensation Act — which still excludes many affected communities.

The scientists measuring fallout knew. Most didn't. Some spoke up. Institutional loyalty, security clearances, and the logic of the Cold War silenced them.

Structural Harms: How the System Produces Bad Outcomes

Publication bias and the file drawer problem

Here's a simple fact: journals prefer positive results. A study showing Drug X does nothing gets rejected — or never submitted. So a study showing Drug X works gets published. The result? The published literature systematically overstates effect sizes.

This isn't fraud. Grants renew on publications. It's incentive structure. That's why careers advance on publications. Negative results don't count.

In psychology

In psychology, the file drawer problem is amplified by a culture that rewards novelty over replication. Early‑career researchers feel pressured to produce striking, counter‑intuitive findings that will stand out in a crowded job market, while attempts to reproduce existing work are often viewed as low‑impact “me‑too” studies and struggle to find a venue. Because of this, many published effects remain unchallenged, and when replication efforts do emerge — often years later — they frequently reveal that the original effect was inflated or absent altogether.

The same incentive structure fuels other questionable research practices. Think about it: 05 threshold, becomes tempting when a single significant result can mean the difference between a grant renewal and a career stall. But p‑hacking, where analysts try multiple specifications until a p‑value falls below the conventional . Selective reporting of outcomes, flexible stopping rules, and undisclosed analytic degrees of freedom all thrive in an environment where success is measured by the quantity and perceived novelty of publications rather than the robustness of the evidence.

Industry sponsorship adds another layer of distortion. When corporations fund studies — whether on pharmaceuticals, nutrition, or environmental toxins — they often retain control over study design, data analysis, and publication decisions. Even when firewalls exist, subtle pressures can steer researchers toward questions that favor the sponsor’s interests and away from those that might threaten them. Disclosure policies help, but they do not eliminate the conflict; they merely make it visible.

These structural pressures are not confined to any single discipline. In climate science, funding cycles tied to political administrations can create periods of neglect for long‑term monitoring programs, leaving gaps that skeptics exploit. Worth adding: in biomedical research, the emphasis on high‑impact journal articles encourages the pursuit of blockbuster findings over incremental, clinically relevant work. Across fields, the metric‑driven evaluation of scientists — h‑index, impact factor, grant dollars — creates a feedback loop where short‑term visibility outweighs long‑term reliability.

Addressing these harms requires rethinking the incentive architecture itself. Journals can adopt registered reports, committing to publish studies based on the rigor of their questions and methods rather than the direction of their results. Which means funding agencies can allocate dedicated streams for replication studies, null‑result publications, and data‑sharing initiatives, treating them as essential infrastructure rather than afterthoughts. Institutions should broaden tenure and promotion criteria to value mentorship, open science practices, and community service alongside traditional publication metrics.

Transparency tools — pre‑registration of hypotheses, open data repositories, and detailed analytic scripts — make it harder to hide unfavorable findings and easier for others to verify claims. When combined with cultural shifts that celebrate careful, reproducible work as much as breakthrough discoveries, these measures can begin to correct the systematic biases that have allowed harmful practices to persist.

When all is said and done, the lessons from lobotomies, nuclear fallout, corporate‑sponsored research, and the file drawer problem converge on a single insight: science is not a self‑cleaning enterprise; it is a human endeavor shaped by the rewards and pressures we impose on it. By aligning those incentives with the core goals of truth‑seeking, openness, and accountability, we can reduce the likelihood that well‑intentioned inquiry becomes a source of harm. The path forward is not to abandon the pursuit of knowledge, but to pursue it in a way that respects both the rigor of the method and the dignity of those it affects.